Alterity Therapeutics Limited Share Price
Stocks
ATH
AU0000043945
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5900 AUD | 0.00% |
|
-7.09% | +47.50% |
| Market Cap | 8.96Cr 7.83Cr 7.23Cr 6.66Cr 13Cr 862.95Cr 13Cr 86Cr 34Cr 422.64Cr 34Cr 33Cr 1.45TCr | P/E 2026 * |
-0.35x | P/E 2027 * | -0.34x |
|---|---|---|---|---|---|
| Enterprise Value | 4.44Cr 3.88Cr 3.58Cr 3.3Cr 6.22Cr 427.78Cr 6.36Cr 43Cr 17Cr 209.51Cr 17Cr 16Cr 721.23Cr | EV / Sales 2026 * |
17.3x | EV / Sales 2027 * | 40.6x |
| Free-Float |
91.76% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Alterity Therapeutics Limited
| 1 week | -7.09% | ||
| Current month | +2.61% | ||
| 1 month | +0.85% | ||
| 3 months | +18.00% | ||
| 6 months | +47.50% | ||
| Current year | +47.50% |
| 1 week | 0.56 |  | 0.64 |
| 1 month | 0.56 | | 0.78 |
| Current year | 0.35 | | 0.78 |
| 1 year | 0.35 | | 0.85 |
| 3 years | 0.1 | | 0.95 |
| 5 years | 0.1 | | 1.9 |
| 10 years | 0.1 | | 20.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 65 | 07/01/2021 |
Abby Niven
DFI | Director of Finance/CFO | - | 30/09/2024 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Marks
BRD | Director/Board Member | 70 | 29/07/2005 |
Lawrence Gozlan
BRD | Director/Board Member | 47 | 08/08/2011 |
David Stamler
BRD | Director/Board Member | 65 | 21/11/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/06/26 | Free | Chairman | 20,00,000 | 0.0184% | ||
| 15/06/26 | Free | Director | 10,00,000 | 0.0092% | ||
| 15/06/26 | Free | Director | 10,00,000 | 0.0092% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -7.09% | -21.33% | +96.67% | 8.96Cr | |
| -1.29% | -3.11% | -0.35% | +3.09% | 4.92TCr | |
| +3.90% | -0.39% | +386.06% | +593.85% | 3.96TCr | |
| -1.70% | +4.46% | +5.93% | +60.25% | 3.47TCr | |
| -2.01% | -0.76% | +28.41% | -8.01% | 3.44TCr | |
| +0.06% | +0.34% | +2.38% | +34.38% | 2.71TCr | |
| +0.46% | -3.49% | - | - | 1.62TCr | |
| -0.04% | -0.09% | +72.42% | +115.55% | 1.54TCr | |
| +1.12% | +1.91% | +14.54% | +19.16% | 1.41TCr | |
| 0.00% | +1.36% | +18.43% | -30.79% | 1.3TCr | |
| Average | +0.05% | -0.69% | +56.28% | +98.24% | 2.44TCr | |
| Weighted average by Cap. | -0.05% | -0.18% | +79.40% | +123.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 25.68L 22.45L 20.71L 19.09L 35.98L 25Cr 36.78L 2.48Cr 97.37L 12Cr 96.46L 94.34L 42Cr | 12L 10.49L 10L 9L 16.82L 12Cr 17.19L 1.16Cr 45.5L 5.66Cr 45.08L 44.09L 19Cr |
| Net income | -1.46Cr -1.28Cr -1.18Cr -1.09Cr -2.05Cr -141.02Cr -2.1Cr -14Cr -5.55Cr -69Cr -5.5Cr -5.38Cr -237.76Cr | -2.97Cr -2.59Cr -2.39Cr -2.2Cr -4.16Cr -285.64Cr -4.25Cr -29Cr -11Cr -139.89Cr -11Cr -11Cr -481.58Cr |
| Net Debt | -4.52Cr -3.95Cr -3.64Cr -3.36Cr -6.33Cr -435.17Cr -6.47Cr -44Cr -17Cr -213.13Cr -17Cr -17Cr -733.69Cr | -4.09Cr -3.57Cr -3.3Cr -3.04Cr -5.73Cr -393.69Cr -5.85Cr -39Cr -15Cr -192.82Cr -15Cr -15Cr -663.76Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | A$0.5900 | 0.00% | 33,706 |
| 16/26/16 | A$0.5900 | +2.61% | 51,964 |
| 15/26/15 | A$0.5750 | -4.17% | 1,22,884 |
| 14/26/14 | A$0.6000 | -5.51% | 3,46,778 |
| 13/26/13 | A$0.6350 | 0.00% | 59,304 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATH Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
